FSHD Society

What FSHD Society does

The FSHD Society is a 501(c)(3) non-profit patient advocacy and research organization founded in 1991 and headquartered in Randolph, Massachusetts. It is the world's largest research-focused organization dedicated to facioscapulohumeral muscular dystrophy (FSHD), a genetic muscle disorder affecting an estimated 870,000 people worldwide (1 in 8,000 incidence). The society serves FSHD patients, families, caregivers, researchers, clinicians, and biopharma companies through education, support services, research funding, clinical trial infrastructure, and advocacy with regulatory bodies including the FDA and international counterparts.

Its core technology platform is BetterLife FSHD, a patient registry and research gateway that captures longitudinal patient-reported outcomes and clinical data to accelerate FSHD clinical trials and drug development. The organization operates the FSHD Clinical Trial Research Network (CTRN), a network of clinical trial sites coordinating FSHD research with biopharma partners, and the Therapeutic Accelerator program, which includes Project Mercury (a global collaboration spanning 10 countries) and the Global FSHD Innovation Hub. Supporting offerings include FSHD Navigator (personalized guidance service), FSHD University (educational webinars and resources), the TestFSHD genetic testing program (partnered with five diagnostic labs), and content platforms including the FSHD Straight Talk Podcast and The FSHD Advocate Magazine. The society also runs 20+ Walk & Roll to Cure FSHD fundraising events across North America and biennial FSHD Connect and FSHD 360 Regional Conferences.

The society generates revenue entirely through individual donations, corporate sponsorships, fundraising events, and grants. Its operations span local chapters across multiple US states and an international footprint via the World FSHD Alliance. The most strategically significant recent move is the April 2026 launch of the FSHD Industry Collaborative with SOLVE FSHD, the CTRN, and key biopharma sponsors Sanofi, Fulcrum Therapeutics, and Scholar Rock, positioning the society as a central convening body for FSHD clinical trial design and regulatory strategy.

Name

FSHD Society

Legal name

FSHD Society

Website

https://fshdsociety.org

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

The FSHD Society is a non-profit patient advocacy and research organization founded in 1991, the world's largest dedicated to facioscapulohumeral muscular dystrophy. It operates patient registries, clinical trial networks, and education programs serving patients, families, researchers, clinicians, and biopharma companies globally.

Ownership category

akta.pro rank

Product category

Rare Disease Patient Advocacy

NAICS

Voluntary Health Organizations (813212)

SIC

Services-Health Services (8000)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Patient advocacy services
• Muscular dystrophy research
• Rare disease support
• Clinical trial networks
• Nonprofit health organization

Headquarters

HQ city

Randolph

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Donations and Fundraising: The FSHD Society generates revenue through donations from individuals, corporate sponsors, and fundraising events such as Walk & Roll to Cure FSHD, direct donations, and planned giving programs.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels11 records

Core offering

The FSHD Society is the world's largest research-focused patient organization for facioscapulohumeral muscular dystrophy (FSHD). It provides patient education, personalized guidance, advocacy with regulatory bodies, and operates a patient registry and clinical trial research network. The organization funds research, hosts educational conferences, and connects patients with healthcare providers and clinical trial opportunities, all delivered free of charge.

Product overview

The FSHD Society operates primarily as a non-profit advocacy and research organization rather than a product company. Its core service offerings include BetterLife FSHD (a patient empowerment platform), the FSHD Navigator (personalized guidance service), FSHD University (educational resources), the FSHD Clinical Trial Research Network (clinical research coordination), and the Therapeutic Accelerator (research program including Project Mercury). The organization also provides community support through local chapters, online communities including Discord, and content platforms including the FSHD Straight Talk Podcast and The FSHD Advocate Magazine. Research support is provided through the BetterLife FSHD Research Gateway, Drug Development Pipeline tracking, and a Genetic Testing Program (TestFSHD). The society organizes fundraising events including the Walk & Roll to Cure FSHD program and educational conferences such as the biennial FSHD Connect Conference and FSHD 360 Regional Conferences.

Differentiator

Problem solved

Functional benefit

Brands

• BetterLife FSHD: A patient registry and research platform designed to help patients take control of their FSHD journey and accelerate treatment development.
• FSHD University
• FSHD Clinical Trial Research Network (CTRN)

Products and services

• BetterLife FSHD A comprehensive patient empowerment platform that enables individuals to take control of their FSHD journey while contributing to research that may help develop potential treatments faster.
• FSHD Navigator Personalized guidance service connecting individuals with real people who provide resources and support for living with FSHD. Available via email and phone.
• FSHD University Educational hub offering webinars, articles, videos, and expert insights on living with and managing FSHD, including topics on physical health, wellness, and vocational rehabilitation services.
• FSHD Clinical Trial Research Network (CTRN) A network of clinical trial sites that coordinates and accelerates FSHD clinical research, working with biopharma companies and academic experts.
• Therapeutic Accelerator Initiative to accelerate FSHD therapeutic development, including Project Mercury and the Global FSHD Innovation Hub.
• FSHD Straight Talk Podcast Podcast series hosted by Tim Hollenback featuring members of the FSHD community who share their experiences living with FSHD. Episodes air on second and fourth Tuesdays of each month.
• The FSHD Advocate Magazine Magazine publication providing news, stories, and information for the FSHD community.
• Walk & Roll to Cure FSHD Annual fundraising event program with locations across North America including Alberta, Chicagoland, Colorado, Ontario, Utah, Michigan, Mid-Atlantic, San Diego, Bay Area, Long Island, St. Louis, New England, New Jersey, Sacramento, North Carolina, NE Florida, Los Angeles, Virginia, Atlanta, Columbus, and Western PA.
• FSHD 360 Regional Conferences Regional educational conferences bringing together patients, families, and experts for empowerment, connection, and care for life with FSHD.
• BetterLife FSHD Research Gateway Portal for researchers to access data, apply for grants, and collaborate on FSHD research initiatives.
• Genetic Testing Program (TestFSHD) Clinically approved genetic testing program established by the FSHD Society to lower barriers to genetic testing for the FSHD community in the US, partnering with labs including Bionano Laboratories, Revvity Omics, University of Iowa Diagnostic Laboratories, Greenwood Genetic Center, and Praxis Genomics.
• FSHD Connect Conference Biennial global gathering dedicated to FSHD patients, families, and experts. The 2026 edition will be held June 26-28, 2026 at Hyatt Regency O'Hare Chicago in Rosemont, IL.

Quantifiable outcome

• 870,000 people worldwide affected by FSHD (1 in 8,000)
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core.

• SOLVE FSHDcoreStrategic or Co-development Partner · 8 April 2026Strategic partner in the FSHD Industry Collaborative launch, working alongside the FSHD Society and FSHD Clinical Trial Research Network to bring together biopharma companies, academic experts, and technology partners.
• FSHD Clinical Trial Research Network (CTRN)coreStrategic or Co-development Partner · 8 April 2026Co-founder of the FSHD Industry Collaborative, providing clinical trial infrastructure and expertise. The CTRN operates clinical trial sites and contributes to biomarker and clinical data analysis for the initiative.
• World FSHD AlliancecoreStrategic or Co-development PartnerInternational alliance of FSHD patient organizations that coordinates global advocacy efforts, shares resources, and unifies the international FSHD community across multiple countries.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Friedreich's Ataxia Research Alliance (FARA): Disease-specific nonprofit driving research for Friedreich's ataxia through patient registries, clinical trial readiness, and biopharma partnerships. Comparable in mission, structure, and the rare-neuromuscular-disease focus to FSHD Society.
• Myotonic Dystrophy Foundation: Patient advocacy and research organization focused on myotonic dystrophy, a related muscular dystrophy. Operates a patient registry, funds research grants, and engages with pharma — closely analogous model to FSHD Society.
• ALS Association: Disease-specific nonprofit for amyotrophic lateral sclerosis (ALS) that funds research, advocates with the FDA, runs care centers, and partners with biopharma on clinical trials. Closely analogous in structure, scale, and stakeholder model to FSHD Society.
• Muscular Dystrophy Association (MDA): U.S.-based nonprofit that funds research and provides care and advocacy across all muscular dystrophies including FSHD. Operates MDA Care Centers, a patient registry, and a research grants program — directly mirroring the FSHD Society's model, just at a much broader disease scope.
• Cure SMA (Spinal Muscular Atrophy): Disease-specific nonprofit for spinal muscular atrophy that built a research and care infrastructure instrumental in bringing multiple approved therapies to market. A leading model for how a focused rare-disease nonprofit can drive therapeutic development, comparable in approach to FSHD Society.
• Charcot-Marie-Tooth Association: Patient advocacy and research nonprofit for Charcot-Marie-Tooth disease, another inherited neuromuscular disorder. Operates patient registries, a clinical care network, and research grants — highly comparable disease-specific neuromuscular nonprofit.
• Parent Project Muscular Dystrophy (PPMD): Disease-specific nonprofit focused on Duchenne muscular dystrophy. Operates a patient registry (Duchenne Registry), certified care center network, and biopharma partnerships — essentially the same operating model as FSHD Society but for a single, different muscular dystrophy.

Broad incumbents

• National Organization for Rare Disorders (NORD): Umbrella advocacy organization for all rare diseases in the U.S., providing policy advocacy, research grants, and patient services. Operates at a broader scope than FSHD Society but represents a higher-level incumbent in the same ecosystem.
• Cystic Fibrosis Foundation: Large, established disease-specific nonprofit that pioneered the venture philanthropy model by funding drug development that yielded multiple approved CF therapies. A scaled-up template of what FSHD Society is attempting with its Therapeutic Accelerator and Industry Collaborative.

Regional players

• World FSHD Alliance: International federation of FSHD patient organizations across multiple countries. Operates as an alliance of national FSHD nonprofits rather than a single patient-services organization, but shares the FSHD-specific mission and overlaps with FSHD Society on global coordination.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/FSHDSociety
• YouTubeyoutube.com/user/FSHSociety
• Facebookfacebook.com/FSHDSociety
• LinkedInlinkedin.com/company/fshd-society
• Instagraminstagram.com/fshdsociety

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FSHD Society